These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 10529757

  • 1. LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are.
    Frikke-Schmidt R, Arlien-Søborg P, Thorsen S, Jensen HK, Vorstrup S.
    Eur J Neurol; 1999 Nov; 6(6):691-6. PubMed ID: 10529757
    [Abstract] [Full Text] [Related]

  • 2. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
    Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG.
    N Engl J Med; 1998 May 28; 338(22):1577-84. PubMed ID: 9603795
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.
    Pedro-Botet J, Sentí M, Nogués X, Rubiés-Prat J, Roquer J, D'Olhaberriague L, Olivé J.
    Stroke; 1992 Nov 28; 23(11):1556-62. PubMed ID: 1440702
    [Abstract] [Full Text] [Related]

  • 4. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
    Gaudet D, Vohl MC, Couture P, Moorjani S, Tremblay G, Perron P, Gagné C, Després JP.
    Atherosclerosis; 1999 Mar 28; 143(1):153-61. PubMed ID: 10208490
    [Abstract] [Full Text] [Related]

  • 5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov 28; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 6. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L, Levy E, Feoli-Fonseca JC, Godbout C, Lambert M.
    Pediatrics; 1995 Aug 28; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review.
    Benn M.
    Atherosclerosis; 2009 Sep 28; 206(1):17-30. PubMed ID: 19200547
    [Abstract] [Full Text] [Related]

  • 8. Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population.
    Benn M, Stene MC, Nordestgaard BG, Jensen GB, Steffensen R, Tybjaerg-Hansen A.
    J Clin Endocrinol Metab; 2008 Mar 28; 93(3):1038-45. PubMed ID: 18160469
    [Abstract] [Full Text] [Related]

  • 9. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L, Freiberger T, Zapletalová P, Soška V, Ravčuková B, Fajkusová L.
    Atherosclerosis; 2012 Aug 28; 223(2):401-8. PubMed ID: 22698793
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
    Gaffney D, Forster L, Caslake MJ, Bedford D, Stewart JP, Stewart G, Wieringa G, Dominiczak M, Miller JP, Packard CJ.
    Atherosclerosis; 2002 May 28; 162(1):33-43. PubMed ID: 11947895
    [Abstract] [Full Text] [Related]

  • 12. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD.
    Clin Chem Lab Med; 2004 May 28; 42(12):1355-63. PubMed ID: 15576296
    [Abstract] [Full Text] [Related]

  • 13. Polymorphisms in apolipoprotein B and risk of ischemic stroke.
    Benn M, Nordestgaard BG, Jensen JS, Tybjaerg-Hansen A.
    J Clin Endocrinol Metab; 2007 Sep 28; 92(9):3611-7. PubMed ID: 17595251
    [Abstract] [Full Text] [Related]

  • 14. [Lipids and lipoproteins in a group of patients with ischemic cerebrovascular disease].
    Scherle CE, Nasiff A, Beguería RA, Pérez-Nellar J, Colina-Rodríguez AJ.
    Rev Neurol; 1998 Nov 28; 27(159):804-8. PubMed ID: 9859156
    [Abstract] [Full Text] [Related]

  • 15. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
    Harano Y, Kageyama A, Nakao Y, Hara Y, Suzuki M, Sato A, Ikebuchi M, Shinozaki K, Tsushima M.
    Diabetes; 1996 Jul 28; 45 Suppl 3():S31-4. PubMed ID: 8674886
    [Abstract] [Full Text] [Related]

  • 16. Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population.
    Benn M, Nordestgaard BG, Jensen JS, Grande P, Sillesen H, Tybjaerg-Hansen A.
    J Clin Endocrinol Metab; 2005 Oct 28; 90(10):5797-803. PubMed ID: 16030169
    [Abstract] [Full Text] [Related]

  • 17. Human hepatic low-density lipoprotein receptors: associations of receptor activities in vitro with plasma lipid and apolipoprotein concentrations in vivo.
    Nanjee MN, Miller NE.
    Biochim Biophys Acta; 1989 Apr 03; 1002(2):245-55. PubMed ID: 2495023
    [Abstract] [Full Text] [Related]

  • 18. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
    Oyelola OO.
    Contraception; 1993 May 03; 47(5):445-54. PubMed ID: 8513671
    [Abstract] [Full Text] [Related]

  • 19. [Influence of plasma lipids, APOE genotype and type of LDL receptor gene mutations on myocardial infarction in subjects with familial hypercholesterolemia].
    Real JT, Ascaso JF, Chaves FJ, González C, Puig O, Armengod ME, Carmena R.
    Med Clin (Barc); 2002 May 18; 118(18):681-5. PubMed ID: 12042130
    [Abstract] [Full Text] [Related]

  • 20. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
    Brousseau ME, Kauffman RD, Herderick EE, Demosky SJ, Evans W, Marcovina S, Santamarina-Fojo S, Brewer HB, Hoeg JM.
    Arterioscler Thromb Vasc Biol; 2000 Feb 18; 20(2):450-8. PubMed ID: 10669643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.